title: Rapid isolation of muscle and heart mitochondria, the lability of oxidative phosphorylation and attempts to stabilize the process in vitro by taurine, carnitine and other compounds.
abstract: We modified the isolation procedure of muscle and heart mitochondria. In human muscle, this resulted in a 3.4 fold higher yield of better coupled mitochondria in half the isolation time. In a preparation from rat muscle we studied factors that affected the stability of oxidative phosphorylation (oxphos) and found that it decreased by shaking the preparation on a Vortex machine, by exposure to light and by an increase in storage temperature. The decay was found to be different for each substrate tested. The oxidation of ascorbate was most stable and less sensitive to the treatments. When mitochondria were stored in the dark and the cold, the decrease in oxidative phosphorylation followed first order kinetics. In individual preparations of muscle and heart mitochondria, protection of oxidative phosphorylation was found by adding candidate stabilizers, such as desferrioxamine, lazaroids, taurine, carnitine, phosphocreatine, N-acetylcysteine. Trolox-C and ruthenium red, implying a role for reactive oxygen species and calcium-ions in the in vitro damage at low temperature to oxidative phosphorylation. In heart mitochondria oxphos with pyruvate and palmitoylcarnitine was most labile followed by glutamate, succinate and ascorbate. We studied the effect of taurine, hypotaurine, carnitine, and desferrioxamine on the decay of oxphos with these substrates. 1 mM taurine (n = 6) caused a significant protection of oxphos with pyruvate, glutamate and palmitoylcarnitine, but not with the other substrates. 5 mM L-carnitine (n = 6), 1 mM hypotaurine (n = 3) and 0.1 mM desferrioxamine (n = 3) did not protect oxphos with any of the substrates at a significant level. These experiments were undertaken in the hope that the in vitro stabilizers can be used in future treatment of patients with defects in oxidative phosphorylation.
authors.affiliation: Department of Biochemistry, Erasmus University, Rotterdam, The Netherlands.
authors.forename: H R
authors.initials: HR
authors.lastname: Scholte
authors.forename: Y
authors.initials: Y
authors.lastname: Yu
authors.forename: J D
authors.initials: JD
authors.lastname: Ross
authors.forename: I I
authors.initials: II
authors.lastname: Oosterkamp
authors.forename: A M
authors.initials: AM
authors.lastname: Boonman
authors.forename: H F
authors.initials: HF
authors.lastname: Busch
mesh_terms: D000818:Animals; D002331:Carnitine / Q000494:pharmacology*; D002458:Cell Fractionation; D006801:Humans; D008929:Mitochondria, Heart / Q000378:metabolism* / Q000648:ultrastructure; D008931:Mitochondria, Muscle / Q000378:metabolism* / Q000648:ultrastructure; D010085:Oxidative Phosphorylation; D051381:Rats; D017208:Rats, Wistar; D013654:Taurine / Q000494:pharmacology*
chemical_list: D013654:Taurine; D002331:Carnitine